drugset / Trial / NCT05613192

Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease Patients

NCT05613192

Phase 3 Unknown 100 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindTreatment

Summary

Aim of work The aim of our study is to assess the effectiveness and safety of high oral loading dose of inactive vitamin D supplementation on the clinical parameters related to liver steatosis, glycaemic control, insulin resistance and metabolic profile in NAFLD patients

Timeline

Start
2022-10-31
Primary completion
2023-03-01
Completion
2023-03-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 800 iu Oral

Indications